[Tumor-specific gene therapy strategy for renal cell carcinomas].
Ogura
Masakazu
M
Department of Radiology, Tenri Hospital.
Shibata
Toru
T
Harada
Hiroshi
H
Hiraoka
Masahiro
M
D002292:Carcinoma, Renal Cell / Q000235:genetics / Q000628:therapy*; D015972:Gene Expression Regulation, Neoplastic; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D000860:Hypoxia; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000502:physiology; D007680:Kidney Neoplasms / Q000235:genetics / Q000628:therapy*; D008156:Luciferases / Q000235:genetics; D009154:Mutation; D011401:Promoter Regions, Genetic; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics / Q000502:physiology
D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D042461:Vascular Endothelial Growth Factor A; D008156:Luciferases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; C497446:VHL protein, human